Current availability status Semaglutide: FDA approved as Wegovy (weight loss) and Ozempic (diabetes) Prescription required Widely available through pharmacies Also available as research chemical Well-established sourcing Cagrilintide: NOT FDA approved (as of 2024) In Phase 3 clinical trials Not commercially available via prescription Only available as research chemical Limited vendors carry it CagriSema (combined product): Novo Nordisk's brand name In Phase 3 trials Not yet approved Anticipated FDA review 2025-2026 Will require prescription when approved Research chemical sourcing For semaglutide: Many established research chemical vendors Quality varies significantly Third-party testing essential Typical cost: $150-300 per 5mg vial Lasts 2-4 weeks at 2.4mg dose For cagrilintide: Very limited vendors currently Newer peptide, less available Quality even more variable Higher cost due to scarcity: $200-400 per 2.4mg vial Many vendors don't carry it yet Quality verification: Certificate of Analysis (COA) required Purity should be 95% Recent testing (within 6 months) Batch number matching Established vendor reputation Red flags: No testing documentation Suspiciously cheap prices New, unknown vendors Poor communication Inconsistent product quality reports See our best peptide vendors , are peptides legal , and research vs pharmaceutical peptides
![louisiana glp-1 gastric stasis lawsuit law office in Ozempic GLP-1 [2026]: Gastroparesis (Stomach Paralysis), Ileus & NAION Vision Loss Injury Cases Woman sues drug makers of](https://bloximages.newyork1.vip.townnews.com/kitv.com/content/tncms/assets/v3/editorial/b/b7/bb740c35-8acc-50a7-9934-3086129ffa25/64cbc493e842e.image.jpg?resize=1396%2C961)
Chen K, Li J, Wang J, Xia Y, Dai W, Wang F, et al
An open veil with exposed gills means the mushroom is more mature and will have a stronger, earthier flavor
Many women also report menstrual irregularities after starting GLP-1 treatment, a side effect that has been observed in recent studies exploring hormonal changes linked to GLP-1 medications
ahin, T